Discovery and Potential Functions of LINC01191 (G440900)

Target Name: LINC01191

NCBI ID: G440900

LINC01191

Discovery and Potential Functions of LINC01191

LINC01191 is a long intergenic non-protein coding RNA (lncRNA) with a transcript variant of 2. It is a non-coding RNA molecule that has been identified as a potential drug target or biomarker.

The discovery of LINC01191

LINC01191 was first identified using RNA sequencing (RNA-seq) data from the human Genomic Reference Consortium (GRC) as a potential non-coding RNA candidate gene. The RNA-seq data showed that LINC01191 was expressed in all four cell types of the human body, including the brain, heart, liver, and muscle.

To further investigate the function of LINC01191, researchers used a variety of techniques to study its expression and localization in various tissues and organs. These studies revealed that LINC01191 was expressed in a variety of tissues and was primarily expressed in the liver, spleen, and pancreas.

In addition, researchers found that LINC01191 was localized to the nuclear envelope in these tissues, which is consistent with its function as a non-protein coding RNA.

The potential drug target

The potential drug target for LINC01191 is its function as a non-protein coding RNA. Non-protein coding RNAs (ncRNAs) have been shown to play a role in a variety of cellular processes, including gene regulation, DNA replication, and RNA translation.

LINC01191 has been shown to regulate the expression of several genes, including the insulin gene. This suggests that it may be involved in the regulation of glucose metabolism, which is a critical process for maintaining energy and life.

In addition, LINC01191 has also been shown to regulate the expression of genes involved in cell signaling, such as the TGF-β pathway. This suggests that it may be involved in the regulation of cellular processes that are important for tissue growth and development.

The potential biomarker

LINC01191 may also be used as a biomarker for a variety of diseases, including cancer. Its function as a non-protein coding RNA suggests that it may be involved in the regulation of gene expression, which is a common process in cancer cells.

In addition, LINC01191 has been shown to be expressed in a variety of cancer types, including breast, ovarian, and colorectal cancers. This suggests that it may be a useful biomarker for these diseases.

Conclusion

LINC01191 is a long intergenic non-protein coding RNA that has been identified as a potential drug target or biomarker. Its function as a non-protein coding RNA suggests that it may be involved in the regulation of gene expression and cellular processes important for tissue growth and development. Further research is needed to fully understand the role of LINC01191 in these processes and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1191

The "LINC01191 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01191 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets